PRELUDE THERAPEUTICS INC's ticker is PRLD and the CUSIP is 74065P101. A total of 56 filers reported holding PRELUDE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $197,349 | -68.3% | 63,867 | -53.9% | 0.00% | – |
| Q2 2023 | $623,218 | +80005.1% | 138,493 | +1.4% | 0.00% | – |
| Q1 2023 | $778 | +159.3% | 136,519 | +174.5% | 0.00% | – |
| Q4 2022 | $300 | -99.9% | 49,736 | -17.7% | 0.00% | – |
| Q3 2022 | $399,000 | -16.0% | 60,426 | -33.6% | 0.00% | – |
| Q2 2022 | $475,000 | +75.3% | 90,937 | +131.3% | 0.00% | – |
| Q1 2022 | $271,000 | -95.1% | 39,311 | -91.1% | 0.00% | -100.0% |
| Q4 2021 | $5,529,000 | +333.0% | 444,111 | +987.1% | 0.00% | +200.0% |
| Q3 2021 | $1,277,000 | +112.8% | 40,851 | +94.9% | 0.00% | – |
| Q2 2021 | $600,000 | +2.6% | 20,958 | +55.2% | 0.00% | – |
| Q1 2021 | $585,000 | -89.8% | 13,503 | -92.9% | 0.00% | -100.0% |
| Q3 2020 | $5,712,000 | – | 189,573 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 10,039,691 | $69,274,000 | 1.12% |
| Baker Brothers Advisors | 10,123,824 | $69,854,000 | 0.40% |
| HHLR ADVISORS, LTD. | 583,333 | $4,025,000 | 0.08% |
| Rock Springs Capital Management LP | 368,959 | $2,546,000 | 0.06% |
| PDT Partners, LLC | 71,822 | $496,000 | 0.04% |
| Virtus ETF Advisers LLC | 13,048 | $90,000 | 0.04% |
| Corton Capital Inc. | 10,918 | $75,000 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 23,201 | $160,000 | 0.02% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 24,238 | $167,000 | 0.01% |
| IndexIQ Advisors LLC | 56,750 | $392,000 | 0.01% |